Long‐Term Outcomes and Predictors in Cancer‐Related Stroke Using the Linked Data Set by Tae Jung Kim, Ji Sung Lee, Mi Sun Oh, Soo‐Hyun Park, Kyung‐Ho Yu, Byung‐Chul Lee, Byung‐Woo Yoon, Sang‐Bae Ko

“…Clinical factors related to outcomes after ischemic stroke, including vascular risk factors, acute stroke management, and types of cancer, were evaluated. …”
Get full text

STUDY OF THE HUMAN PAPILLOMA VIRUS PREVALENCE AND ITS PHYSICAL STATUS IN PATIENS WITH NON-SMALL CELL LUNG CANCER by M. K. Ibragimova, M. M. Tsyganov, A. M. Pevzner, E. O. Rodionov, O. V. Cheremisina, S. V. Miller, S. A. Tuzikov, N. V. Litviakov

“…In Russia, there are no reports regarding the studies of viral contribution to lung carcinogenesis.The aim of the present study was to examine the presence of high-risk HpV infection in patients with non-small cell lung cancer (NSCLC).Material and Methods. …”
Get full text

Knowledge and awareness of cervical cancer and human papillomavirus vaccination among female university students by Charles C. Ndubuisi, Olga Maphasha, Sunday O. Okeke

“…Background: Prevention strategies for reducing cervical cancer incidence rely on informed populations, particularly those most at risk. …”
Get full text

Utility of computerized tomography in clinical staging and surgical decision making in patients with uterine cancer by Andrew Tannous, Alexzandra Adler, Jeanelle Sheeder, Rebecca J. Wolsky, Jill Alldredge

Get full text

Clinicopathological features, risk model and prognosis of 115 cases of epithelioid hemangioendothelioma: A single-center study by Shihui Zhang, Yiting Liang, Ye Yang, Lei Guo, Weihua Li, Susheng Shi

“…ObjectiveTo investigate the clinicopathological features, diagnostic value, risk model and prognostic significance of epithelioid hemangioendothelioma (EHE) in a retrospective cohort of 115 cases.MethodsA total of 115 cases of EHE diagnosed in the Cancer Hospital of the Chinese Academy of Medical Sciences (NCC) from 2011 to 2023 were collected. …”
Get full text

Repeatability and prognostic value of radiomic features: a study in esophageal cancer and nasopharyngeal carcinoma by Jie Gong, Fan Meng, Changhao Liu, Jianchao Lu, Jie Li, Zhi Yang, Hongfei Sun, Xinzhi Teng, Jiang Zhang, Jing Cai, Mei Shi, Lina Zhao

“…RF repeatability was assessed via perturbation analysis using intraclass correlation coefficients (ICC), with consistency and differences across cancer types, pathological regions, and modalities evaluated. …”
Get full text

Exploration of shared pathogenic factors and causative genes in early-stage endometrial cancer and osteoarthritis by Yiyun Bai, Sang Luo, Ruzhen Shuai, Xiaomei Zhang, Liwei Yuan, Dan Liu

“…Abstract Osteoarthritis (OA) has been implicated in the development and progression of early-stage endometrial cancer (EC), suggesting shared pathogenic factors between the two diseases. …”
Get full text

Gleason score and docetaxel response in advanced hormone-sensitive prostate cancer: The lower the better by Omer Dizdar, Deniz Can Guven, Gurkan Guner, Mustafa Erman, Mutlu Hayran

“…Keywords: Hormone-sensitive, prostate cancer, docetaxel, gleason score…”
Get full text

CO03 | Early discharge and home treatment of low-risk pulmonary embolism: a cohort study

“… Background and Aims: Pulmonary embolism (PE) is a common condition with a wide variety of clinical presentations and severities, making early mortality risk assessment essential to defining the most appropriate management strategy. …”
Get full text

Common molecular links and therapeutic insights between type 2 diabetes and kidney cancer. by Reaz Ahmmed, Mohammad Amirul Islam, Md Taohid Hasan, Arnob Sarker, Md Ahad Ali, Md Saiful Islam, Mst Zafrin Sultana, Md Nurul Haque Mollah

“…Type 2 diabetes (T2D) is considered as a risk factor for kidney cancer (KC). However, so far, there is no study in the literature that has explored genetic factors through which T2D drive the development and progression of KC. …”
Get full text

Evaluating a Chatbot as a Companion for Patients With Breast Cancer: Collaborative Pilot Study by Sebastian Daniel Boie, Esther Glastetter, Michael Patrick Lux, Felix Balzer, Christof von Kalle, Christian Lenz, Ulrike Müller

“…A customized version of GPT-4 was configured with specific system prompts emphasizing empathetic, evidence-based responses and integrated with a comprehensive database comprising guidelines, recommendations, and patient information materials published by recognized German medical societies. To assess chatbot responses, we used 4 evaluation criteria: comprehensibility (clarity from a patient perspective), correctness (accuracy per current medical guidelines), completeness (inclusion of all relevant aspects), and potential harm (risk of undue patient harm or misinformation). …”
Get full text

Decoding the hypoxic tumor microenvironment in colorectal cancer for prognostic modeling and therapeutic target discovery by Xiao-Cui Duan, Yan Zhou, Fan Feng, Hai-Bo Jiang, Mei-Lin Wang, Zhe Han, Hong-Fei Pang, Yu-Hang Liu, Heng-Zhe Jia, Meng- He, Hong-Pan Xu, Yuan-Yuan Wang

“…BackgroundHypoxia is a hallmark of the colorectal cancer (CRC) tumor microenvironment (TME) that drives malignant progression, chemoresistance, and immune evasion. …”
Get full text

Effects of auriculotherapy on urinary incontinence in men with prostate cancer: a randomized controlled trial by Ying Zhang, Siyuan Wu, Keping Zhu, Kun Li, Ziyi Qi, Binbin Zhu, Sijia Hou, Wei Wang

“…This study aimed to assess the effectiveness of auriculotherapy on urinary incontinence in men with prostate cancer. …”
Get full text

Utility of dual-energy contrast-enhanced spectral mammography for the diagnosis of multicentric breast cancer by A. V. Chyornaya, R.  Kh. Ulyanova, P.  V. Krivorotko, A. S. Artemyeva, S. S. Bagnenko, E. K. Zhiltsova, S. N. Novikov, V. V. Danilov, P.  I. Krzhivitskiy, V. F. Semiglazov

“…Background. Breast cancer (BC) can be unifocal, multifocal, multicentric (MCBC) and bilateral according to number and localization of tumors. …”
Get full text

Insights from age-stratified endoscopic detection metrics support initiating colorectal cancer screening at age 45 by Majd Khader, Jorge-Shmuel Delgado, Rimon Artoul, Asher Shafrir, Abu-Freha Naim

“…Abstract Background and aim All major U.S. guidelines now validate average-risk colorectal cancer (CRC) screening at 45–49 years of age. …”
Get full text

A nanoencapsulated oral formulation of fenretinide promotes local and metastatic breast cancer dormancy in HER2/neu transgenic mice by Maria Laura De Angelis, Federica Francescangeli, Eleonora Aricò, Paola Verachi, Massimo Zucchetti, Cristina Matteo, Elena Petricci, Emanuela Pilozzi, Isabella Orienti, Alessandra Boe, Adriana Eramo, Rachele Rossi, Tiberio Corati, Daniele Macchia, Anna Maria Pacca, Ann Zeuner, Marta Baiocchi

“…We recently generated a new micellar formulation of FeR, Bionanofenretinide (Bio-nFeR) showing enhanced bioavailability, low toxicity, and strong antitumor efficacy on human lung cancer, colorectal cancer, and melanoma xenografts. …”
Get full text

The status of occult HBV infection in a high endemic region: risk of community HBV transmission and reactivation by Hussein Mukasa Kafeero, Ponsiano Ocama, Dorothy Ndagire, Abdul Walusansa, Mariam Namusoke, Ali Kudamba, Fahad Muwanda, Hakim Sendagire

Get full text

Implementing comprehensive geriatric assessment in an academic hematologic outpatient setting: experiences from medical doctors and patients by Steven Pierre Hiltgen, Heike A. Bischoff-Ferrari, Heike A. Bischoff-Ferrari, Michael Gagesch, Michael Gagesch, Michael Gagesch, Alexander Kaltenborn, Markus G. Manz, Max J. Rieger, Rahel Schwotzer, Sebastian M. Stolz, Thorsten Zenz, Wiebke Rösler

“…Major oncology societies recommend a screening for geriatric impairments in patients at risk (e.g. G8), followed by a comprehensive geriatric assessment (CGA). …”
Get full text

Unveiling the causative role of promoter variant rs113823671 in MMP7 in gallbladder cancer susceptibility by Vinay Jeeyar, Kusumbati Besra, Shivaram Prasad Singh, Manjusha Dixit

“…We hypothesized that promoter SNPs could modulate MMP7 expression, thus impacting GBC susceptibility. Our study aimed to assess the aberrant expression levels and genetic polymorphisms of MMP7 as potential risk factors for GBC. …”
Get full text

Efficacy and safety of Nivolumab in advanced gastric and gastroesophageal junction cancer: a meta-analysis of randomized controlled trials by Xinming Lei, Weimin Huo, Tian Xu, Jianguang Xu, Maoning Liu, Chengjiang Liu, Zhangyuan Gu

“…Conclusion Nivolumab, both alone and in combination with chemotherapy, improves OS and PFS in patients with advanced gastric and gastroesophageal junction cancer. However, careful patient monitoring is necessary due to the increased risk of severe AEs, particularly with monotherapy.…”
Get full text